Blogroll
- Ben’s Stem Cell News
- Biosingularity
- Biotech Blog
- Cell WISE
- CellTherapyBlog
- CellTherapyNews
- Fierce Biotech
- Fredrick County, MD Biotech Community
- Hematopoiesis
- IN VIVO blog
- Life Sciences Chronicle
- List of Biotech Conferences
- My Biotech Life
- Partial Immortalization
- Stem Cell Patents
- The Niche
- The Stem Cell
- US PTO
- Venture Beat – Lifesciences
- Wired Blogs – Science
- WordPress.com
Cool Regenmed Jobs
- Biomaterials and Diabetes Scientists at Living Cell Technologies (New Zealand)
- Cell and Tissue Culture Technicians at Pharmacell (ex-US)
- Cell Culture, Bioprocess, Analytical, and Tissue Engineering positions open at Tengion
- Cell Process Development and Production Positions at Cognate Bioservices
- Cell Therapy Business Development Leader at Invitrogen
- Jobs at Geron: chemists, process and product development, cell biology, immunology, assay development, and quality positions
- Manufacturing Manager at Cognate Bioservices
- Process Dev, R&D, Quality and other jobs at Tigenix (Belgium and US)
- RegenMed Scientists and Research Associates at Athersys
- Research and Quality positions at Biomimetic Therapeutics
General Science
Local Biotech Gateways
Other Biotech Blogs
Patents
Archives
Catagory Cloud
adult stem cell Advanced Cell Technology Apptec Athersys BD Big Pharma Biomaterials Bioprocessing business models cardiac regeneration cell delivery Clinical Trials combination products Company Profiles Embyonic Stem Cells FDA Geron Innovation Intellectual Property Invitrogen JNJ Job search Joint Ventures Manufacturing Novocell Osiris Regenerative Medicine regulatory stem cells vascular regeneration
Category Archives: Cytori
The Developing Embyronic Stem Cell Clinical Landscape
ES cell biopsy from blastocyst. Continue reading
Posted in adult stem cell, Advanced Cell Technology, Athersys, Clinical Trials, Cytori, Embyonic Stem Cells, FDA, Geron, JNJ, Novocell, Osiris, Regenerative Medicine, spinal cord injury, stem cells
Tagged Clinical Trials, embryonic vs adult stem cell, embyryonic stem cell 2008, evolving clinical landscape, safety issues
Leave a comment
Cytori Announces Progress in Cardiac Regeneration Clinical Studies
Cytori Therapeutics announced that they have enrolled their first two patients in an acute myocardial infarction clinical trial using adipose-derived cells prepared using their Celution™ device. The Celution™ device is an automated, tissue processing unit that isolates cells from adipose … Continue reading
The Regeneration Station 